Takumi Nakamura

Maebashi, Japan

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications

Drebrin is a novel biomarker of cognitive deterioration in Alzheimer's disease.

Drebrin is a novel biomarker of cognitive deterioration in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD
Published: January 02, 2026

Clinical Validation of Plasma p-217tau in Neurological Diseases.

Clinical Validation of Plasma p-217tau in Neurological Diseases.

Journal: Annals of clinical and translational neurology
Published: November 25, 2025

White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.

White matter lesions rather than amyloid-β burden are associated with cognitive decline in Alzheimer's disease.

Journal: Journal of Alzheimer's disease : JAD
Published: February 16, 2025

A case of the iatrogenic transmission of vascular Aß40 amyloid.

A case of the iatrogenic transmission of vascular Aß40 amyloid.

Journal: Amyloid : the international journal of experimental and clinical investigation : the official journal of the International Society of Amyloidosis
Published: October 29, 2024

High levels of plasma neurofilament light chain correlated with brainstem and peripheral nerve damage.

High levels of plasma neurofilament light chain correlated with brainstem and peripheral nerve damage.

Journal: Journal of the neurological sciences
Published: May 27, 2024

Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.

Clinical Evaluation of Cerebrospinal Fluid p217tau and Neurofilament Light Chain Levels in Patients with Alzheimer's Disease or Other Neurological Diseases.

Journal: Journal of Alzheimer's disease : JAD
Published: November 26, 2023

Role of complement activation and disruption of the blood-brain barrier in the pathogenesis of multiple system atrophy.

Role of complement activation and disruption of the blood-brain barrier in the pathogenesis of multiple system atrophy.

Journal: Neuroscience letters
Published: November 20, 2023

A case of chronic progressive autoimmune GFAP astrocytopathy with extensive meningoencephalomyelitis and contrast enhancement on MRI.

A case of chronic progressive autoimmune GFAP astrocytopathy with extensive meningoencephalomyelitis and contrast enhancement on MRI.

Journal: eNeurologicalSci
Published: August 26, 2023

Coupling of Cortical Hyperintense Signals and Increased Glucose Metabolism in a Case of Anti-GABAA Receptor Antibody-associated Encephalitis.

Coupling of Cortical Hyperintense Signals and Increased Glucose Metabolism in a Case of Anti-GABAA Receptor Antibody-associated Encephalitis.

Journal: Internal medicine (Tokyo, Japan)
Published: April 16, 2023

Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.

Plasma ApoE4 Levels Are Lower than ApoE2 and ApoE3 Levels, and Not Associated with Plasma Aβ40/42 Ratio as a Biomarker of Amyloid-β Amyloidosis in Alzheimer's Disease.

Journal: Journal of Alzheimer's disease : JAD
Published: March 27, 2023

Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia.

Striatal dopamine transporter binding differs between dementia with Lewy bodies and Parkinson's disease with dementia.

Journal: Journal of the neurological sciences
Published: December 30, 2022

Annual stability of the plasma Aß40/42 ratio and associated factors.

Annual stability of the plasma Aß40/42 ratio and associated factors.

Journal: Annals of clinical and translational neurology
Published: December 13, 2022
Showing 1-12 of 35

Last Updated: 09/26/2026